Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
International Journal of Oncology|July 31, 2003
IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitorTakemi Otsuki, Haruko Sakaguchi, Masaaki Eto, et al.CPT: Pharmacometrics & Systems Pharmacology|February 17, 2023
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19Ryo Tamura, Kei Irie, Atsushi Nakagawa, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
Lipids behavior and adverse effects for oral antidiabetic agents in patients with Type 2 diabetes treated with sulfonylureas alone based on systematic reviewJunichi Mukai, Hitoshi Tada, Yuka Watanabe, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2002
Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patientsMasaaki Eto, Mieko Saito, Mizuho Okada, et al.CPT: Pharmacometrics & Systems Pharmacology|July 22, 2021
Population pharmacokinetics of favipiravir in patients with COVID-19Kei Irie, Atsushi Nakagawa, Hirotoshi Fujita, et al.Therapeutic Drug Monitoring|July 13, 2022
Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung CancerMakiko Tohi, Kei Irie, Tomoyuki Mizuno, et al.Clinical Case Reports|February 18, 2021
Plasma concentration of amitriptyline and metabolites after resuscitation from cardiopulmonary arrest following an overdose: A case reportMotozumi Ando, Ryo Tamura, Shinji Nakasako, et al.Diabetes Care|May 27, 2004
Effect of apolipoprotein E4 allele on plasma LDL cholesterol response to diet therapy in type 2 diabetic patientsMieko Saito, Masaaki Eto, Hayami Nitta, et al.Journal of Atherosclerosis and Thrombosis|December 6, 2011
Management of type IIb dyslipidemiaHidenori Arai, Shun Ishibashi, Hideaki Bujo, et al.Journal of Atherosclerosis and Thrombosis|December 2, 2011
Diagnosis and management of type I and type V hyperlipoproteinemiaTakanari Gotoda, Koji Shirai, Takao Ohta, et al.Pageof 3